HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL* INJECTABLE, (a) 10ml (b) 9ml injectable, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

Recall Insight

This FDA Drug action (record #D-1089-2019) was formally reported on April 17, 2019, with the manufacturer initiating the action on February 21, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy is listed as the recalling firm, operating out of Corvallis, OR. Federal records indicate 4 prescriptions 9 & 10ml injectable units are affected.

The documented reason for this recall is: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection. Distribution data in the federal record shows the product reached: Dispensed in Oregon. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 5 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 7 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.